(Q48806045)

15 February 2018

title

Practical benefit of [123I]FP-CIT SPET in the demonstration of the dopaminergic deficit in Parkinson's disease. (English)

1 reference

15 February 2018

1 reference

1 reference

Booij J

1

1 reference

15 February 2018

Tissingh G

2

1 reference

15 February 2018

Winogrodzka A

3

1 reference

15 February 2018

Boer GJ

4

1 reference

15 February 2018

Stoof JC

5

1 reference

15 February 2018

Wolters EC

6

1 reference

15 February 2018

van Royen EA

7

1 reference

15 February 2018

publication date

1 January 1997

1 reference

15 February 2018

European Journal of Nuclear Medicine and Molecular Imaging

published in

1 reference

15 February 2018

volume

24

1 reference

15 February 2018

page(s)

68-71

1 reference

15 February 2018

issue

1

1 reference

15 February 2018

https://scigraph.springernature.com/pub.10.1007/bf01728311

exact match

0 references

cites work

Graphical, kinetic, and equilibrium analyses of in vivo [123I] beta-CIT binding to dopamine transporters in healthy human subjects.

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF01728311

The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease

21 January 2018

1 reference

12 December 2020

Decreased single-photon emission computed tomographic [123I]beta-CIT striatal uptake correlates with symptom severity in Parkinson's disease.

1 reference

12 December 2020

Comparison of iodine-123 labelled 2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane and 2 beta-carbomethoxy-3 beta-(4-iodophenyl)-N-(3-fluoropropyl)nortropane for imaging of the dopamine transporter in the living human brain.

1 reference

12 December 2020

Regional brain uptake and pharmacokinetics of [123I]N-omega-fluoroalkyl-2 beta-carboxy-3 beta-(4-iodophenyl)nortropane esters in baboons

1 reference

12 December 2020

SPECT imaging of dopamine and serotonin transporters with [123I]?-CIT. Binding kinetics in the human brain

1 reference

12 December 2020

N-omega-fluoroalkyl analogs of (1R)-2 beta-carbomethoxy-3 beta-(4-iodophenyl)-tropane (beta-CIT): radiotracers for positron emission tomography and single photon emission computed tomography imaging of dopamine transporters.

1 reference

12 December 2020

[O-methyl-11C]beta-CIT-FP, a potential radioligand for quantitation of the dopamine transporter: preparation, autoradiography, metabolite studies, and positron emission tomography examinations

1 reference

12 December 2020

SPECT imaging of dopamine transporters in human brain with iodine-123-fluoroalkyl analogs of beta-CIT.

1 reference

12 December 2020

Evaluation of [123I] beta-CIT binding with SPECT in controls, early and late Parkinson's disease.

1 reference

12 December 2020

[123I]FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson's disease

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01728311

1 reference

15 February 2018

PubMed ID

9044880

1 reference

15 February 2018